KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2025)

Historic Inventory Average for Rigel Pharmaceuticals (RIGL) over the last 8 years, with Q3 2025 value amounting to $11.9 million.

  • Rigel Pharmaceuticals' Inventory Average rose 8473.88% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 8473.88%. This contributed to the annual value of $5.8 million for FY2024, which is 2128.42% down from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Inventory Average stood at $11.9 million for Q3 2025, which was up 8473.88% from $7.5 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Inventory Average registered a high of $11.9 million during Q3 2025, and its lowest value of $4.3 million during Q1 2021.
  • Its 5-year average for Inventory Average is $7.3 million, with a median of $6.8 million in 2021.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 31681.79% in 2021, then crashed by 4007.92% in 2024.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Inventory Average stood at $6.8 million in 2021, then increased by 18.92% to $8.1 million in 2022, then fell by 28.34% to $5.8 million in 2023, then fell by 7.29% to $5.4 million in 2024, then skyrocketed by 119.97% to $11.9 million in 2025.
  • Its Inventory Average was $11.9 million in Q3 2025, compared to $7.5 million in Q2 2025 and $5.3 million in Q1 2025.